Debbie K. Everidge
Direttore Tecnico/Scientifico/R&S presso MILESTONE PHARMACEUTICALS INC.
Provenienza dei contatti di primo grado di Debbie K. Everidge
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Debbie K. Everidge tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer Treasurer | |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| University of Wisconsin | College/University | Undergraduate Degree Graduate Degree | |
| Motorola Automotive & Industrial Electronics Group | Corporate Officer/Principal | ||
| GENMARK DIAGNOSTICS, INC. | Medical Specialties | Director/Board Member | |
| McGill University | College/University | Graduate Degree | |
Celerion, Inc.
 Celerion, Inc. Miscellaneous Commercial ServicesCommercial Services Celerion, Inc. provides clinical research solutions and applied translational medicine. Its services include global clinical research, clinical pharmacology sciences, global bioanalytical services, and drug development services. The company was founded in 2010 and is headquartered in Lincoln, NE. | Miscellaneous Commercial Services | Director/Board Member | |
MDS Pharma Services (Canada)
 MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Searle Canada, Inc. | Corporate Officer/Principal | ||
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HCW BIOLOGICS INC. | Biotechnology | Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| Art Institute of Chicago | College/University | Director/Board Member | |
| G.D. Searle LLC | Corporate Officer/Principal | ||
Giles & Associates Consultancy
 Giles & Associates Consultancy Miscellaneous Commercial ServicesCommercial Services Giles & Associates Consultancy provides management consulting services for the healthcare industry. The private company is based in Lake Bluff, IL. The company was founded by Lisa M. Giles. Lisa M. Giles has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Optivara, Inc. | Chief Executive Officer | ||
| ABIOMED, INC. | Medical Specialties | Director of Finance/CFO | |
| Haptocure Ltd. | Director/Board Member | ||
| Juniata College | College/University | Undergraduate Degree | |
| Northwestern Memorial Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Cimeio Therapeutics AG
 Cimeio Therapeutics AG Packaged SoftwareTechnology Services Cimeio Therapeutics AG is an applied gene editing and immunotherapy company based in Basel, Switzerland. Cimeio is developing a portfolio of shielded-cell & immunotherapy pairs™ (scip) that have the potential to transform hematopoietic stem cell transplant. The Swiss company's technology platform is based on the design and expression of modified variants of naturally occurring cell surface proteins in hscs. These novel variants maintain their function but are resistant to depletion when targeted by a paired immunotherapy which has high affinity for the wild-type version of these proteins. Cimeio is the leader of the field of epitope editing and is developing a portfolio of shielded-cell & immunotherapy pairs™ (scip), novel immunotherapies which have the potential to transform treatment of hematologic diseases. The company develops state-of-the-art immunotherapies, along with paired, modified variants of naturally occurring cell surface proteins in hscs. These immunotherapies have significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with hematologic malignancies, autoimmune disorders, and genetic diseases. The company was founded by Lukas Jeker and the CEO is Thomas Fuchs. | Packaged Software | Director/Board Member | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director of Finance/CFO | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member | |
The Lexington
 The Lexington Medical/Nursing ServicesHealth Services Part of The Ensign Group, Inc., The Lexington operates a 125-bed assisted living facility. The company is based in Ventura, CA. | Medical/Nursing Services | Director of Finance/CFO | |
General Electric Healthcare Technologies, Inc.
 General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services General Electric Healthcare Technologies, Inc. provides transformational medical technologies and services. The company is headquartered in Houston, TX. | Medical/Nursing Services | Corporate Officer/Principal | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Concordia University | College/University | Undergraduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| University of Messiah | College/University | Undergraduate Degree | |
| Wilmington University | College/University | Graduate Degree | |
| Salve Regina University | College/University | Undergraduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Graduate Degree | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOXCEL THERAPEUTICS, INC. | Biotechnology | Human Resources Officer | |
| Eastern Michigan University | College/University | Masters Business Admin | |
| Indian Institute of Management & Commerce | College/University | Undergraduate Degree | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Haverford College | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 38 |
| Canada | 6 |
| Svizzera | 4 |
| Israele | 2 |
| Giappone | 2 |
Settori
| Health Technology | 24 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Health Services | 3 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 49 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 20 |
| Undergraduate Degree | 16 |
| Chairman | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| Paul Truex | 17 |
| Seth Fischer | 17 |
| Richard Pasternak | 16 |
| Robert Wills | 13 |
| Lisa Giles | 12 |
| Debra Liebert | 12 |
| Michael Tomsicek | 12 |
| Amit Hasija | 7 |
| Douglas Wight | 7 |
| Joseph Oliveto | 7 |
| Lorenz Muller | 6 |
| Francis Plat | 6 |
| Guy Rousseau | 5 |
| Kimberly Sheehan | 5 |
| Jeff Nelson | 4 |
- Borsa valori
- Insiders
- Debbie K. Everidge
- Connessioni Società
